Other
National Research Program for Biopharmaceuticals, Taiwan
Total Trials
5
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
Failure Rate
0.0%
0 terminated/withdrawn out of 5 trials
Success Rate
100.0%
+13.5% vs industry average
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
67%
2 of 3 completed trials have results
Key Signals
2 with results
Enrollment Performance
Analytics
N/A
3(60.0%)
Phase 2
2(40.0%)
5Total
N/A(3)
Phase 2(2)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (5)
Showing 5 of 5 trials
NCT02467608Phase 2Completed
Efficacy of HUEXC030 in Subjects With Pulmonary Tuberculosis
Role: collaborator
NCT03321396Not ApplicableCompleted
Hydrogel Injection to Assist Endoscopic Submucosal Dissection
Role: collaborator
NCT03239652Not ApplicableUnknown
Taiwan ACE Beads for Embolization Therapy in Symptomatic Benign Prostatic Hyperplasia
Role: collaborator
NCT02825550Not ApplicableCompleted
Taiwan ACE Beads for Hepatoma Embolization Therapy
Role: collaborator
NCT02855658Phase 2Unknown
Modulation of Immunity-related Gene Expression Under the Chinese Herbal Formula SS-1 Treatment for Sjögren's Syndrome
Role: collaborator
All 5 trials loaded